Publication date: October 2026 Source: Thrombosis Research, Volume 266 Author(s): Won Kee Ahn, Chuhl Joo Lyu, Jung Woo Han, Hugh Chul Kim, Soyon Kim, Ji Yoon Kim, Ye Jee Shim, Sung Eun Kim, Hee Jo Baek, Bo Ram Kim, Jeong A. Park, Ji Kyoung Park, Hoi Soo Yoon, Kyung Mi Park, Eun Sun Yoo, Hyun Sik Kang, Seung Min Hahn, Young-Shil Park
Real-world effectiveness of emicizumab prophylaxis in Korean patients with severe hemophilia A. // Thrombosis Research. – URL: https://www.sciencedirect.com/science/article/pii/S0049384826003257?dgcid=rss_sd_all
Real-world effectiveness of emicizumab prophylaxis in Korean patients with severe hemophilia A. Thrombosis Research. https://www.sciencedirect.com/science/article/pii/S0049384826003257?dgcid=rss_sd_all
“Real-world effectiveness of emicizumab prophylaxis in Korean patients with severe hemophilia A.” Thrombosis Research.
@article{article69737,
title = {Real-world effectiveness of emicizumab prophylaxis in Korean patients with severe hemophilia A},
journal = {Thrombosis Research},
url = {https://www.sciencedirect.com/science/article/pii/S0049384826003257?dgcid=rss_sd_all}
}